News archive
News archive 14/08/2006
Four-Drug Combo Is No Improvement Over Standard Three-Drug Regimen in Suppressing HIV
Adding a fourth medication to a standard three-drug "cocktail" employed to suppress HIV and prevent AIDS does not improve the effectiveness of treatment, concludes a major multicenter clinical trial led by physician-scientists at NewYork-Presbyterian Hospital/Weill Cornell Medical Center in New York City.
News archive 14/08/2006
Wear and Tear of Stress: The Psychoneurobiology of Aging
Age may be more related to reactions to stress and the absence of disease rather than to a person’s chronological age, say leading researchers in the fields of neurobiology and psychoneuroendocrinology. And healthy aging is a good bet if stress can be moderated along with adopting an active, healthy lifestyle.
News archive 14/08/2006
Computer Scientists Lay Out Vision for a ”Science of the Web“
Researchers need a clear agenda to harness the rapidly evolving potential of the World Wide Web, according to an article in the Aug. 11 issue of the journal Science. Calling for the creation of an interdisciplinary ”science of the Web,“ a group of computer scientists suggests the need for new approaches to tap the full richness of this powerful tool, while ensuring that it develops in a way that benefits society as a whole.
News archive 14/08/2006
Harper lambasted for skipping AIDS conference
United Nations envoy Stephen Lewis said Sunday that Prime Minister Stephen Harper's decision not to attend the six-day International AIDS Conference taking place in Toronto is a "terrible mistake."
News archive 14/08/2006
Human Rights And Social Responsibilities - XVI International AIDS Conference
Anand Grover (India), Co-Founder of the Lawyers Collective HIV/AIDS Unit, delivered the Jonathan Mann Memorial Lecture, named in memory of scientist Jonathan Mann, credited with building the World Health Organization1s AIDS programme from the ground up.
News archive 14/08/2006
Uniting for HIV Prevention: UNAIDS, civil society, treatment activists, private sector and governments call for 'out of the ordinary partnerships' to intensify HIV prevention efforts.
Representatives from the International Council of AIDS Service Organizations (ICASO), the Treatment Action Campaign (TAC), the governments of India and Sweden and Merck pharmaceuticals outlined the concept of 'uniting for HIV prevention' at a press conference on the second day of the XVI International AIDS Conference, taking place in Toronto, Canada.
News archive 13/08/2006
copied as fair use; AA Further lessons from the TGN1412 tragedy
New guidelines call for a change in the culture of research
News archive 13/08/2006
Vertex Pharmaceuticals Incorporated (VRTX) Release: Updated HIV Treatment Guidelines Now Include LEXIVA(R) (fosamprenavir calcium)/r For Initial Antiretroviral Treatment Regimens
The IAS-USA commissions expert panels to issue recommendations and guidelines to provide standard approaches to patient care. The updated guidelines published in the current issue of the Journal of the American Medical Association (JAMA) stated that, "[t]he choice of initial drug centers on acceptability; predicted tolerance; pill burden; comorbid conditions; short-term, mid-term and long term adverse event profiles."
News archive 13/08/2006
Thousands of experts and activists in Toronto for AIDS conference
Since the beginning of the pandemic, nearly 65 million people worldwide have been infected with HIV and AIDS has killed more than 25 million people.
News archive 13/08/2006
'We know what needs to happen to beat this disease'
Our collective response to this pandemic, Bill Clinton writes, will define us for generations to come
News archive 12/08/2006
China urges methadone therapy
THE Chinese government is vigorously promoting methadone replacement therapy to drug addicts to curb the spread of AIDS and hepatitis caused by injections.
News archive 12/08/2006
The race is on for Canadian firms
HIV 'too clever' for single approach, so combining drugs could be best way to keep it at bay
News archive 12/08/2006
The promise of microbicides
According to the World Health Organization, women account for nearly 70 per cent of HIV-AIDS cases worldwide
News archive 11/08/2006
Gilead Sciences and Merck Establish Agreement for Distribution of ATRIPLA(TM) in Developing Countries
Gilead Sciences, Inc. (Nasdaq: GILD) and Merck & Co., Inc. (NYSE: MRK) today announced that the companies have established an agreement for the distribution of ATRIPLA(TM) (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), a once-daily, single tablet regimen for the treatment of HIV-1 infection in adults, in developing countries around the world.
News archive 10/08/2006
AIDS virus hides out in "accomplice" cells
The AIDS virus has an accomplice that helps it infect the immune system cells it attacks -- other immune system cells, U.S. researchers reported on Saturday.
More...
